Showing results (371-380 of 401) with videos related to

Sort By:
Pageof 41
Clinical Nephrology|May 29, 2009
Beneficial effects of high-dose losartan in IgA nephritisK-T Woo, C-M Chan, H-K Tan, et al.
European Urology Oncology|July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 PatientsJustin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesW P Yong, B C Goh, R A Soo, et al.
Molecular Pharmacology|September 28, 2011
Identification of a novel allosteric binding site in the CXCR2 chemokine receptorPetra de Kruijf, Herman D Lim, Luc Roumen, et al.
Urologic Oncology|July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinomaDaniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
European Journal of Pharmacology|April 5, 2011
N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 releaseSaskia A Overbeek, Paul A J Henricks, Anja I Srienc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.
Clinical Nephrology|October 29, 2010
The changing pattern of primary glomerulonephritis in Singapore and other countries over the past 3 decadesK-T Woo, C-M Chan, C Y Mooi, et al.
European Urology Oncology|July 6, 2019
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II TrialNizar M Tannir, Pavlos Msaouel, Jeremy A Ross, et al.
The Biochemical Journal|May 3, 2008
Cloning and characterization of dominant negative splice variants of the human histamine H4 receptorRichard M van Rijn, André van Marle, Paul L Chazot, et al.
Pageof 41